Ray Dalio's HCA Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 329,307 shares of HCA Healthcare, Inc. (HCA) worth $153.74 M, representing 0.56% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in HCA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 220,512 shares. Largest reduction occurred in Q3 2022, reducing 123,477 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -11,250 | Reduce 3.30% | 329,307 | $466.86 |
| Q3 2025 | -66,149 | Reduce 16.26% | 340,557 | $426.20 |
| Q2 2025 | -22,020 | Reduce 5.14% | 406,706 | $383.10 |
| Q1 2025 | -41,827 | Reduce 8.89% | 428,726 | $345.55 |
| Q4 2024 | +220,512 | Add 88.19% | 470,553 | $300.15 |
| Q3 2024 | -45,857 | Reduce 15.50% | 250,041 | $406.43 |
| Q2 2024 | -50,415 | Reduce 14.56% | 295,898 | $321.28 |
| Q1 2024 | -79,963 | Reduce 18.76% | 346,313 | $333.53 |
| Q4 2023 | +50,568 | Add 13.46% | 426,276 | $270.68 |
| Q3 2023 | +72,965 | Add 24.10% | 375,708 | $245.98 |
| Q2 2023 | -37,992 | Reduce 11.15% | 302,743 | $303.48 |
| Q1 2023 | -4,720 | Reduce 1.37% | 340,735 | $263.68 |
| Q4 2022 | -26,585 | Reduce 7.15% | 345,455 | $239.96 |
| Q3 2022 | -123,477 | Reduce 24.92% | 372,040 | $183.79 |
| Q2 2022 | +106,167 | Add 27.27% | 495,517 | $168.06 |
| Q1 2022 | +76,485 | Add 24.45% | 389,350 | $250.62 |
| Q4 2021 | -28,510 | Reduce 8.35% | 312,865 | $256.92 |
| Q3 2021 | +57,603 | Add 20.30% | 341,375 | $242.72 |
| Q2 2021 | +121,089 | Add 74.43% | 283,772 | $206.74 |
| Q1 2021 | -4,223 | Reduce 2.53% | 162,683 | $188.34 |
| Q4 2020 | +94,121 | Add 129.31% | 166,906 | $164.46 |
| Q3 2020 | +60,482 | Add 491.60% | 72,785 | $124.68 |
| Q2 2020 | -6,279 | Reduce 33.79% | 12,303 | $97.05 |
| Q1 2020 | +18,582 | New Buy | 18,582 | $89.87 |
Ray Dalio's HCA Healthcare Investment FAQs
Ray Dalio first purchased HCA Healthcare, Inc. (HCA) in Q1 2020, acquiring 18,582 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held HCA Healthcare, Inc. (HCA) for 24 quarters since Q1 2020.
Ray Dalio's largest addition to HCA Healthcare, Inc. (HCA) was in Q4 2024, adding 470,553 shares worth $141.24 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 329,307 shares of HCA Healthcare, Inc. (HCA), valued at approximately $153.74 M.
As of the Q4 2025 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.56% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in HCA Healthcare, Inc. (HCA) was 495,517 shares, as reported at the end of Q2 2022.